TASHINA BLAIR: Open Payments
NPI 1952079931 · SALEM, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,339 in 40 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $183 · 2025 $2,339
Travel & lodging: $1,203Food & beverage: $1,136
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 16 | $1,718 |
| Dexcom, Inc. | 1 | $138 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $78 |
| Madrigal Pharmaceuticals | 2 | $66 |
| GlaxoSmithKline, LLC. | 3 | $61 |
| BETA BIONICS, INC. | 3 | $51 |
| Xeris Pharmaceuticals, Inc. | 2 | $39 |
| Amgen Inc. | 2 | $36 |
| Lilly USA, LLC | 1 | $26 |
| Azurity Pharmaceuticals, Inc. | 1 | $24 |
Products named: MINIMED 780G, DEXCOM G7 GSS (161), Kerendia, REZDIFFRA, iLet Bionic Pancreas, EVENITY, MOUNJARO, HORIZANT.
Industry payments across OR — which companies pay providers there.
